

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 4.64425036 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.24940596 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.24225314 |
| 4 | proline biosynthetic process (GO:0006561) | 4.15007878 |
| 5 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.03952933 |
| 6 | epithelial cell-cell adhesion (GO:0090136) | 4.03859076 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 4.01249134 |
| 8 | complement activation, alternative pathway (GO:0006957) | 4.00881098 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 3.96395337 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.95866830 |
| 11 | protein carboxylation (GO:0018214) | 3.95866830 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 3.95764072 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95764072 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 3.95315379 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 3.95315379 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 3.94848181 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.94848181 |
| 18 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.85621507 |
| 19 | urea metabolic process (GO:0019627) | 3.81080545 |
| 20 | urea cycle (GO:0000050) | 3.81080545 |
| 21 | kynurenine metabolic process (GO:0070189) | 3.73466113 |
| 22 | proline metabolic process (GO:0006560) | 3.70961141 |
| 23 | regulation of protein activation cascade (GO:2000257) | 3.69872947 |
| 24 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.69864998 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68265556 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 3.68224031 |
| 27 | protein retention in ER lumen (GO:0006621) | 3.67094854 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 3.64758119 |
| 29 | glyoxylate metabolic process (GO:0046487) | 3.62931622 |
| 30 | regulation of fibrinolysis (GO:0051917) | 3.60845414 |
| 31 | low-density lipoprotein particle clearance (GO:0034383) | 3.59821185 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 3.57821118 |
| 33 | regulation of complement activation (GO:0030449) | 3.52746455 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51732956 |
| 35 | regulation of cholesterol homeostasis (GO:2000188) | 3.51381283 |
| 36 | plasma lipoprotein particle clearance (GO:0034381) | 3.50968643 |
| 37 | negative regulation of fatty acid transport (GO:2000192) | 3.49275329 |
| 38 | lung epithelium development (GO:0060428) | 3.48492568 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.46438269 |
| 40 | lysine metabolic process (GO:0006553) | 3.45186853 |
| 41 | lysine catabolic process (GO:0006554) | 3.45186853 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 3.42284024 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 3.42284024 |
| 44 | tryptophan catabolic process (GO:0006569) | 3.42284024 |
| 45 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.39322027 |
| 46 | cell-substrate junction assembly (GO:0007044) | 3.38924749 |
| 47 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.38064498 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.38039417 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.38039417 |
| 50 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.37812359 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 3.37548653 |
| 52 | activation of Rac GTPase activity (GO:0032863) | 3.35127390 |
| 53 | cysteine metabolic process (GO:0006534) | 3.32978647 |
| 54 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.31475525 |
| 55 | reverse cholesterol transport (GO:0043691) | 3.30356649 |
| 56 | tryptophan metabolic process (GO:0006568) | 3.26829189 |
| 57 | regulation of apoptotic cell clearance (GO:2000425) | 3.25268021 |
| 58 | serine family amino acid catabolic process (GO:0009071) | 3.23482711 |
| 59 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.21104476 |
| 60 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.20812127 |
| 61 | bile acid biosynthetic process (GO:0006699) | 3.20211316 |
| 62 | phospholipid homeostasis (GO:0055091) | 3.19871222 |
| 63 | semaphorin-plexin signaling pathway (GO:0071526) | 3.17827796 |
| 64 | adherens junction assembly (GO:0034333) | 3.16864887 |
| 65 | cell-substrate adherens junction assembly (GO:0007045) | 3.15344347 |
| 66 | focal adhesion assembly (GO:0048041) | 3.15344347 |
| 67 | hemidesmosome assembly (GO:0031581) | 3.13876648 |
| 68 | positive regulation of lipid catabolic process (GO:0050996) | 3.13567301 |
| 69 | regulation of cholesterol metabolic process (GO:0090181) | 3.12448083 |
| 70 | phospholipid efflux (GO:0033700) | 3.12299753 |
| 71 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.11979606 |
| 72 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.10121213 |
| 73 | lipoprotein metabolic process (GO:0042157) | 3.09941163 |
| 74 | basement membrane organization (GO:0071711) | 3.06802425 |
| 75 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.06015813 |
| 76 | ethanol oxidation (GO:0006069) | 3.05514455 |
| 77 | atrioventricular valve morphogenesis (GO:0003181) | 3.03658474 |
| 78 | negative regulation of sterol transport (GO:0032372) | 3.03605128 |
| 79 | negative regulation of cholesterol transport (GO:0032375) | 3.03605128 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.02718131 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.02718131 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.02718131 |
| 83 | positive regulation of fatty acid oxidation (GO:0046321) | 3.01947470 |
| 84 | intestinal absorption (GO:0050892) | 2.98958435 |
| 85 | NADH metabolic process (GO:0006734) | 2.96032060 |
| 86 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94230697 |
| 87 | 4-hydroxyproline metabolic process (GO:0019471) | 2.93241539 |
| 88 | bile acid metabolic process (GO:0008206) | 2.92128044 |
| 89 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.91744558 |
| 90 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.91311895 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 2.90750683 |
| 92 | regulation of extracellular matrix disassembly (GO:0010715) | 2.88752064 |
| 93 | fatty acid beta-oxidation (GO:0006635) | 2.88150428 |
| 94 | epoxygenase P450 pathway (GO:0019373) | 2.87891114 |
| 95 | glycine metabolic process (GO:0006544) | 2.86571238 |
| 96 | glucose 6-phosphate metabolic process (GO:0051156) | 2.86551082 |
| 97 | cell-cell junction maintenance (GO:0045217) | 2.85145416 |
| 98 | regulation of cholesterol storage (GO:0010885) | 2.85137637 |
| 99 | fibrinolysis (GO:0042730) | 2.84516077 |
| 100 | * cholesterol homeostasis (GO:0042632) | 2.81227651 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 2.80957267 |
| 102 | fatty acid transmembrane transport (GO:1902001) | 2.80942066 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.79548217 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.79548217 |
| 105 | * sterol homeostasis (GO:0055092) | 2.78708990 |
| 106 | valine metabolic process (GO:0006573) | 2.78579505 |
| 107 | bile acid and bile salt transport (GO:0015721) | 2.78457311 |
| 108 | negative regulation of lipase activity (GO:0060192) | 2.78347672 |
| 109 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.78293414 |
| 110 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.76850856 |
| 111 | cellular modified amino acid catabolic process (GO:0042219) | 2.76743750 |
| 112 | skin morphogenesis (GO:0043589) | 2.76412960 |
| 113 | paraxial mesoderm development (GO:0048339) | 2.76317048 |
| 114 | cholesterol efflux (GO:0033344) | 2.76094007 |
| 115 | regulation of triglyceride metabolic process (GO:0090207) | 2.76022942 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 2.74771421 |
| 117 | alpha-amino acid catabolic process (GO:1901606) | 2.74615685 |
| 118 | fatty acid oxidation (GO:0019395) | 2.74604404 |
| 119 | endothelial cell morphogenesis (GO:0001886) | 2.74435699 |
| 120 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.73259968 |
| 121 | regulation of sequestering of triglyceride (GO:0010889) | 2.73084631 |
| 122 | 2-oxoglutarate metabolic process (GO:0006103) | 2.73063798 |
| 123 | positive regulation of extracellular matrix organization (GO:1903055) | 2.72184576 |
| 124 | regulation of plasminogen activation (GO:0010755) | 2.72010328 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 2.71989463 |
| 126 | regulation of extracellular matrix organization (GO:1903053) | 2.71165312 |
| 127 | protein-lipid complex assembly (GO:0065005) | 2.69590926 |
| 128 | carnitine metabolic process (GO:0009437) | 2.69018544 |
| 129 | tyrosine metabolic process (GO:0006570) | 2.68416026 |
| 130 | negative regulation of cell size (GO:0045792) | 2.66928962 |
| 131 | linoleic acid metabolic process (GO:0043651) | 2.66858031 |
| 132 | lipid oxidation (GO:0034440) | 2.66818336 |
| 133 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.64690287 |
| 134 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.62319488 |
| 135 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.61965819 |
| 136 | regulation of bile acid biosynthetic process (GO:0070857) | 2.61717355 |
| 137 | apoptotic cell clearance (GO:0043277) | 2.59404572 |
| 138 | aromatic amino acid family metabolic process (GO:0009072) | 2.59281517 |
| 139 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.56167069 |
| 140 | cellular amino acid catabolic process (GO:0009063) | 2.54399665 |
| 141 | establishment of apical/basal cell polarity (GO:0035089) | 2.51091722 |
| 142 | biotin metabolic process (GO:0006768) | 2.50779154 |
| 143 | plasma lipoprotein particle organization (GO:0071827) | 2.46638192 |
| 144 | endothelial cell chemotaxis (GO:0035767) | 2.46484266 |
| 145 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.45777403 |
| 146 | diacylglycerol metabolic process (GO:0046339) | 2.45316177 |
| 147 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.44435327 |
| 148 | negative regulation of lipid transport (GO:0032369) | 2.43738908 |
| 149 | * branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.42607270 |
| 150 | ethanol metabolic process (GO:0006067) | 2.40674750 |
| 151 | positive regulation of steroid metabolic process (GO:0045940) | 2.39687441 |
| 152 | maternal placenta development (GO:0001893) | 2.39453971 |
| 153 | protein-lipid complex subunit organization (GO:0071825) | 2.38987904 |
| 154 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.38424849 |
| 155 | renal system development (GO:0072001) | 2.37044231 |
| 156 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.36602055 |
| 157 | low-density lipoprotein particle remodeling (GO:0034374) | 2.35174200 |
| 158 | receptor catabolic process (GO:0032801) | 2.34249623 |
| 159 | gap junction assembly (GO:0016264) | 2.33727594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.85467211 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.15817390 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04234970 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.86004928 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.68229242 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.23462964 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.18705881 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09817170 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.96721299 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.74668586 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.65060857 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57110167 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.36106159 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.32622153 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.31172466 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30663139 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25703780 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.03975906 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.00274930 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95937443 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91978829 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83239575 |
| 23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76662994 |
| 24 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.67624212 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64589840 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.62742806 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61319591 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.57782467 |
| 29 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57351291 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55956728 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.54858699 |
| 32 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53628928 |
| 33 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53395531 |
| 34 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50470659 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50134868 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.47468285 |
| 37 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.47432978 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47373833 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45057208 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44279930 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43976568 |
| 42 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43199531 |
| 43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42403424 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40350666 |
| 45 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39565760 |
| 46 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39397010 |
| 47 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39397010 |
| 48 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.39397010 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36567282 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35642024 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33569428 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33403925 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32985333 |
| 54 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.32541619 |
| 55 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.32541619 |
| 56 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31523855 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30766490 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30245993 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.29874642 |
| 60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29813365 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27177880 |
| 62 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26135033 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26105189 |
| 64 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24705551 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23985391 |
| 66 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23505651 |
| 67 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23384498 |
| 68 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23112393 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23027742 |
| 70 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.21396780 |
| 71 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21071074 |
| 72 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20966262 |
| 73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20615462 |
| 74 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19181224 |
| 75 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.19064371 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18967695 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17080151 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16277031 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16157556 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11665490 |
| 81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10055097 |
| 82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09907671 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08277062 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05474897 |
| 85 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05006952 |
| 86 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04842933 |
| 87 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04677234 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04669376 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04576143 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04129033 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03481993 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02724112 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02571280 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02478399 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01739660 |
| 96 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01240086 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01081128 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00609354 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00026963 |
| 100 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99082661 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98692079 |
| 102 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97916623 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97916623 |
| 104 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97791541 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97635283 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97504104 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97080261 |
| 108 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96664649 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95819337 |
| 110 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95352766 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95212978 |
| 112 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.94823303 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94301232 |
| 114 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94107474 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93278502 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93195399 |
| 117 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91189216 |
| 118 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89344953 |
| 119 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88980042 |
| 120 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88186049 |
| 121 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86897350 |
| 122 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84795650 |
| 123 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84542874 |
| 124 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83629539 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83173475 |
| 126 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.83035839 |
| 127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82899922 |
| 128 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82178313 |
| 129 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.81746741 |
| 130 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.79633721 |
| 131 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.79616851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.21510666 |
| 2 | MP0005360_urolithiasis | 4.09557910 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.91941174 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.44093648 |
| 5 | MP0005365_abnormal_bile_salt | 3.39782559 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.11533762 |
| 7 | MP0003252_abnormal_bile_duct | 2.77114749 |
| 8 | MP0005275_abnormal_skin_tensile | 2.33510088 |
| 9 | MP0009840_abnormal_foam_cell | 2.23705013 |
| 10 | MP0004272_abnormal_basement_membrane | 2.18742095 |
| 11 | * MP0010329_abnormal_lipoprotein_level | 2.13676343 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11358500 |
| 13 | MP0005409_darkened_coat_color | 2.10973915 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.10281668 |
| 15 | MP0004858_abnormal_nervous_system | 2.06091366 |
| 16 | MP0005670_abnormal_white_adipose | 2.04093979 |
| 17 | MP0010368_abnormal_lymphatic_system | 1.99841616 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 1.88921573 |
| 19 | MP0003566_abnormal_cell_adhesion | 1.86866363 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.78480365 |
| 21 | MP0002089_abnormal_postnatal_growth/wei | 1.71893193 |
| 22 | MP0005083_abnormal_biliary_tract | 1.68213356 |
| 23 | MP0000751_myopathy | 1.62865729 |
| 24 | MP0000678_abnormal_parathyroid_gland | 1.60088843 |
| 25 | MP0002060_abnormal_skin_morphology | 1.56330265 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.52985994 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.49199655 |
| 28 | MP0004782_abnormal_surfactant_physiolog | 1.45349096 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.44998169 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.44996357 |
| 31 | MP0000003_abnormal_adipose_tissue | 1.43355197 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.43169738 |
| 33 | * MP0000609_abnormal_liver_physiology | 1.42521305 |
| 34 | MP0002254_reproductive_system_inflammat | 1.40973560 |
| 35 | MP0009053_abnormal_anal_canal | 1.35137341 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.32583974 |
| 37 | MP0005023_abnormal_wound_healing | 1.32379369 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.29083261 |
| 39 | MP0004264_abnormal_extraembryonic_tissu | 1.28505991 |
| 40 | MP0003279_aneurysm | 1.27700896 |
| 41 | MP0002796_impaired_skin_barrier | 1.25108496 |
| 42 | MP0001849_ear_inflammation | 1.22930649 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.22856930 |
| 44 | MP0003123_paternal_imprinting | 1.22184321 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.21495812 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.20989077 |
| 47 | MP0005248_abnormal_Harderian_gland | 1.20207681 |
| 48 | MP0005332_abnormal_amino_acid | 1.19192394 |
| 49 | MP0001661_extended_life_span | 1.18983113 |
| 50 | * MP0002118_abnormal_lipid_homeostasis | 1.16875801 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.16469215 |
| 52 | MP0003283_abnormal_digestive_organ | 1.14889022 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.12964762 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.12682841 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.09037528 |
| 56 | MP0000534_abnormal_ureter_morphology | 1.08607468 |
| 57 | MP0000462_abnormal_digestive_system | 1.08424548 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.07143638 |
| 59 | MP0004233_abnormal_muscle_weight | 1.06724476 |
| 60 | MP0003942_abnormal_urinary_system | 1.06295517 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.05815352 |
| 62 | MP0000767_abnormal_smooth_muscle | 1.03047361 |
| 63 | MP0001958_emphysema | 1.01720100 |
| 64 | MP0000579_abnormal_nail_morphology | 1.00708717 |
| 65 | MP0003941_abnormal_skin_development | 0.98304109 |
| 66 | MP0000858_altered_metastatic_potential | 0.98190956 |
| 67 | * MP0002896_abnormal_bone_mineralization | 0.97228092 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.95488167 |
| 69 | MP0003045_fibrosis | 0.94199887 |
| 70 | MP0004130_abnormal_muscle_cell | 0.92711913 |
| 71 | MP0001348_abnormal_lacrimal_gland | 0.92072072 |
| 72 | MP0000733_abnormal_muscle_development | 0.91887306 |
| 73 | MP0003315_abnormal_perineum_morphology | 0.91477844 |
| 74 | MP0004084_abnormal_cardiac_muscle | 0.91420679 |
| 75 | MP0010630_abnormal_cardiac_muscle | 0.90184975 |
| 76 | MP0000598_abnormal_liver_morphology | 0.89468781 |
| 77 | MP0001730_embryonic_growth_arrest | 0.88946276 |
| 78 | MP0003115_abnormal_respiratory_system | 0.88182283 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.87476336 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.86778701 |
| 81 | MP0002168_other_aberrant_phenotype | 0.86608856 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.86433990 |
| 83 | MP0009643_abnormal_urine_homeostasis | 0.85849522 |
| 84 | MP0009278_abnormal_bone_marrow | 0.85183017 |
| 85 | MP0005501_abnormal_skin_physiology | 0.84350440 |
| 86 | MP0001243_abnormal_dermal_layer | 0.82267879 |
| 87 | MP0006138_congestive_heart_failure | 0.82051192 |
| 88 | MP0002970_abnormal_white_adipose | 0.80530706 |
| 89 | MP0000537_abnormal_urethra_morphology | 0.80224736 |
| 90 | MP0002249_abnormal_larynx_morphology | 0.79327152 |
| 91 | MP0001915_intracranial_hemorrhage | 0.78942840 |
| 92 | MP0000477_abnormal_intestine_morphology | 0.77533359 |
| 93 | MP0003868_abnormal_feces_composition | 0.77454390 |
| 94 | MP0005451_abnormal_body_composition | 0.76635068 |
| 95 | MP0002697_abnormal_eye_size | 0.76565056 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.75488902 |
| 97 | MP0009115_abnormal_fat_cell | 0.75048378 |
| 98 | MP0002098_abnormal_vibrissa_morphology | 0.74951970 |
| 99 | * MP0002086_abnormal_extraembryonic_tissu | 0.74832585 |
| 100 | MP0002932_abnormal_joint_morphology | 0.74575034 |
| 101 | MP0003195_calcinosis | 0.74450722 |
| 102 | MP0008260_abnormal_autophagy | 0.73772366 |
| 103 | MP0003385_abnormal_body_wall | 0.73770433 |
| 104 | MP0002128_abnormal_blood_circulation | 0.73310146 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.73115102 |
| 106 | MP0005330_cardiomyopathy | 0.73059685 |
| 107 | MP0003329_amyloid_beta_deposits | 0.72415870 |
| 108 | MP0003828_pulmonary_edema | 0.71828258 |
| 109 | MP0009672_abnormal_birth_weight | 0.71271942 |
| 110 | MP0000762_abnormal_tongue_morphology | 0.70411103 |
| 111 | MP0005647_abnormal_sex_gland | 0.70325421 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.69778566 |
| 113 | MP0004087_abnormal_muscle_fiber | 0.68287019 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.67987304 |
| 115 | MP0002092_abnormal_eye_morphology | 0.67591893 |
| 116 | MP0001216_abnormal_epidermal_layer | 0.67020588 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.66857863 |
| 118 | * MP0001614_abnormal_blood_vessel | 0.66433406 |
| 119 | MP0010771_integument_phenotype | 0.65893517 |
| 120 | MP0009931_abnormal_skin_appearance | 0.65885649 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.65884187 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.65751841 |
| 123 | MP0005334_abnormal_fat_pad | 0.65176271 |
| 124 | MP0003091_abnormal_cell_migration | 0.65174556 |
| 125 | MP0002971_abnormal_brown_adipose | 0.64345629 |
| 126 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63744286 |
| 127 | MP0002282_abnormal_trachea_morphology | 0.63599940 |
| 128 | * MP0004197_abnormal_fetal_growth/weight/ | 0.62940851 |
| 129 | * MP0002925_abnormal_cardiovascular_devel | 0.62386844 |
| 130 | * MP0005508_abnormal_skeleton_morphology | 0.61037779 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.60681110 |
| 132 | MP0002111_abnormal_tail_morphology | 0.59918114 |
| 133 | MP0002269_muscular_atrophy | 0.59753448 |
| 134 | MP0009763_increased_sensitivity_to | 0.59455225 |
| 135 | MP0000377_abnormal_hair_follicle | 0.59057753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.87016805 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.09694748 |
| 3 | Complement deficiency (HP:0004431) | 4.07213450 |
| 4 | Xanthomatosis (HP:0000991) | 3.99324558 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.91419626 |
| 6 | Protrusio acetabuli (HP:0003179) | 3.78310606 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 3.47670928 |
| 8 | Increased connective tissue (HP:0009025) | 3.30723435 |
| 9 | Premature rupture of membranes (HP:0001788) | 3.24317546 |
| 10 | Ankle contracture (HP:0006466) | 3.21352115 |
| 11 | Abnormality of complement system (HP:0005339) | 3.21311016 |
| 12 | Flat acetabular roof (HP:0003180) | 3.19608335 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.10459961 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 3.09728053 |
| 15 | Broad metatarsal (HP:0001783) | 3.08983361 |
| 16 | Atrophic scars (HP:0001075) | 3.08612327 |
| 17 | Broad face (HP:0000283) | 3.07838448 |
| 18 | Myocardial infarction (HP:0001658) | 3.04578666 |
| 19 | Shallow orbits (HP:0000586) | 3.02478368 |
| 20 | Hyperacusis (HP:0010780) | 3.00460638 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 2.98382471 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 2.96493377 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 2.94254675 |
| 24 | Esophageal varix (HP:0002040) | 2.91000718 |
| 25 | Hypolipoproteinemia (HP:0010981) | 2.87802645 |
| 26 | Epidermoid cyst (HP:0200040) | 2.87570424 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.86670557 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.75133206 |
| 29 | Joint hemorrhage (HP:0005261) | 2.74275260 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.71797361 |
| 31 | Abnormality of carpal bone ossification (HP:0006257) | 2.70889671 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 2.61896580 |
| 33 | Peritonitis (HP:0002586) | 2.61487227 |
| 34 | Hyperglycinuria (HP:0003108) | 2.61279481 |
| 35 | Asymmetry of the thorax (HP:0001555) | 2.60805219 |
| 36 | Hyperammonemia (HP:0001987) | 2.59077276 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 2.55318523 |
| 38 | Hypercholesterolemia (HP:0003124) | 2.53433494 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.52711666 |
| 40 | Vertebral compression fractures (HP:0002953) | 2.48528734 |
| 41 | Distal upper limb amyotrophy (HP:0007149) | 2.47584968 |
| 42 | Upper limb amyotrophy (HP:0009129) | 2.47584968 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.43684062 |
| 44 | Abnormal ossification of hand bones (HP:0005921) | 2.42357944 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.37881842 |
| 46 | * Hemorrhage of the eye (HP:0011885) | 2.37580034 |
| 47 | Advanced eruption of teeth (HP:0006288) | 2.36818376 |
| 48 | Arterial tortuosity (HP:0005116) | 2.35944185 |
| 49 | Bronchomalacia (HP:0002780) | 2.35730259 |
| 50 | Pterygium (HP:0001059) | 2.34940897 |
| 51 | Alopecia of scalp (HP:0002293) | 2.34856337 |
| 52 | Ketosis (HP:0001946) | 2.31907994 |
| 53 | Mitral valve prolapse (HP:0001634) | 2.31743819 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30094940 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.29066064 |
| 56 | Lymphangioma (HP:0100764) | 2.28699950 |
| 57 | Skin nodule (HP:0200036) | 2.27335980 |
| 58 | Short nail (HP:0001799) | 2.27155197 |
| 59 | Type 1 muscle fiber predominance (HP:0003803) | 2.27098714 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 2.22767528 |
| 61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.22767528 |
| 62 | Abnormality of the Achilles tendon (HP:0005109) | 2.22319898 |
| 63 | Thin bony cortex (HP:0002753) | 2.20504599 |
| 64 | Vascular tortuosity (HP:0004948) | 2.19693691 |
| 65 | Fragile skin (HP:0001030) | 2.19202252 |
| 66 | Turricephaly (HP:0000262) | 2.17582966 |
| 67 | Nephritis (HP:0000123) | 2.17438130 |
| 68 | Aortic dissection (HP:0002647) | 2.17182927 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.12288669 |
| 70 | Ventricular tachycardia (HP:0004756) | 2.12149031 |
| 71 | Vascular calcification (HP:0004934) | 2.10991471 |
| 72 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.09878960 |
| 73 | Glomerulonephritis (HP:0000099) | 2.07173472 |
| 74 | Focal segmental glomerulosclerosis (HP:0000097) | 2.05503122 |
| 75 | Abnormality of the acetabulum (HP:0003170) | 2.04926707 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.03537796 |
| 77 | Premature skin wrinkling (HP:0100678) | 2.02820268 |
| 78 | Wormian bones (HP:0002645) | 2.02753028 |
| 79 | Fat malabsorption (HP:0002630) | 2.02610068 |
| 80 | Coxa vara (HP:0002812) | 2.02223659 |
| 81 | Biconcave vertebral bodies (HP:0004586) | 2.00975781 |
| 82 | Ulnar bowing (HP:0003031) | 2.00094765 |
| 83 | Blue sclerae (HP:0000592) | 1.99715540 |
| 84 | Milia (HP:0001056) | 1.99453465 |
| 85 | Hyperglycinemia (HP:0002154) | 1.99399251 |
| 86 | Pseudobulbar signs (HP:0002200) | 1.97297463 |
| 87 | Rectal prolapse (HP:0002035) | 1.97215051 |
| 88 | * Aneurysm (HP:0002617) | 1.96157509 |
| 89 | Abnormal hand bone ossification (HP:0010660) | 1.95905134 |
| 90 | Stridor (HP:0010307) | 1.95835880 |
| 91 | Bladder diverticulum (HP:0000015) | 1.95140070 |
| 92 | Trismus (HP:0000211) | 1.95093197 |
| 93 | Spinal rigidity (HP:0003306) | 1.95062380 |
| 94 | Follicular hyperkeratosis (HP:0007502) | 1.94331243 |
| 95 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.93658178 |
| 96 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.91969693 |
| 97 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91428141 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 1.91204785 |
| 99 | Hydroxyprolinuria (HP:0003080) | 1.91204785 |
| 100 | Aortic aneurysm (HP:0004942) | 1.91117350 |
| 101 | Polycythemia (HP:0001901) | 1.90707087 |
| 102 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88674753 |
| 103 | Disproportionate tall stature (HP:0001519) | 1.88554065 |
| 104 | Spastic diplegia (HP:0001264) | 1.86030530 |
| 105 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84283265 |
| 106 | Ectopia lentis (HP:0001083) | 1.82671760 |
| 107 | Malnutrition (HP:0004395) | 1.82413469 |
| 108 | Obstructive sleep apnea (HP:0002870) | 1.82318449 |
| 109 | Abnormality of nucleobase metabolism (HP:0010932) | 1.81754726 |
| 110 | Distal lower limb muscle weakness (HP:0009053) | 1.81345428 |
| 111 | Cervical subluxation (HP:0003308) | 1.81193520 |
| 112 | Hyporeflexia of lower limbs (HP:0002600) | 1.80515658 |
| 113 | Glomerulosclerosis (HP:0000096) | 1.79633161 |
| 114 | Neonatal short-limb short stature (HP:0008921) | 1.79456876 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 1.78629195 |
| 116 | Menorrhagia (HP:0000132) | 1.76851018 |
| 117 | J-shaped sella turcica (HP:0002680) | 1.75230043 |
| 118 | Ketoacidosis (HP:0001993) | 1.74602942 |
| 119 | Hematochezia (HP:0002573) | 1.74122313 |
| 120 | Mitral stenosis (HP:0001718) | 1.73047383 |
| 121 | Renovascular hypertension (HP:0100817) | 1.72973785 |
| 122 | Natal tooth (HP:0000695) | 1.72939606 |
| 123 | Back pain (HP:0003418) | 1.72867556 |
| 124 | Hypoplastic ischia (HP:0003175) | 1.72013920 |
| 125 | Renal duplication (HP:0000075) | 1.71842227 |
| 126 | Cupped ribs (HP:0000887) | 1.71361732 |
| 127 | Acanthosis nigricans (HP:0000956) | 1.70769314 |
| 128 | Neonatal death (HP:0003811) | 1.70094398 |
| 129 | Slender build (HP:0001533) | 1.69552372 |
| 130 | Mitral regurgitation (HP:0001653) | 1.69488980 |
| 131 | Abnormality of dentin (HP:0010299) | 1.68725342 |
| 132 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68651344 |
| 133 | Abnormality of the 4th metacarpal (HP:0010012) | 1.68462709 |
| 134 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.68313671 |
| 135 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68313671 |
| 136 | Aplasia involving bones of the extremities (HP:0009825) | 1.68313671 |
| 137 | Abnormality of purine metabolism (HP:0004352) | 1.67692609 |
| 138 | Abnormality of methionine metabolism (HP:0010901) | 1.67677933 |
| 139 | Osteolytic defects of the hand bones (HP:0009699) | 1.67634497 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.67634497 |
| 141 | Abnormal vertebral ossification (HP:0100569) | 1.66333453 |
| 142 | Muscle fiber splitting (HP:0003555) | 1.66188292 |
| 143 | Abnormal tarsal ossification (HP:0008369) | 1.65177533 |
| 144 | Abdominal distention (HP:0003270) | 1.64598623 |
| 145 | Hyperglycemia (HP:0003074) | 1.64461118 |
| 146 | Wrist flexion contracture (HP:0001239) | 1.64158220 |
| 147 | Increased mean platelet volume (HP:0011877) | 1.63932752 |
| 148 | Growth hormone excess (HP:0000845) | 1.62608406 |
| 149 | Hypertriglyceridemia (HP:0002155) | 1.61773754 |
| 150 | Abnormal delivery (HP:0001787) | 1.61376601 |
| 151 | Reticulocytosis (HP:0001923) | 1.60863612 |
| 152 | Ankyloglossia (HP:0010296) | 1.59953767 |
| 153 | Hand muscle atrophy (HP:0009130) | 1.57773423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 3.72762524 |
| 2 | EPHA2 | 3.53871195 |
| 3 | LATS1 | 3.51780549 |
| 4 | TRIB3 | 3.32930293 |
| 5 | ERN1 | 3.21793304 |
| 6 | PKN2 | 3.05124624 |
| 7 | SMG1 | 2.72279651 |
| 8 | CDK12 | 2.61504432 |
| 9 | TGFBR2 | 2.47234043 |
| 10 | TTN | 2.37734820 |
| 11 | RIPK1 | 2.19112197 |
| 12 | FGFR4 | 2.08870137 |
| 13 | TIE1 | 2.03838958 |
| 14 | EEF2K | 2.02927705 |
| 15 | BCKDK | 1.99224267 |
| 16 | PDGFRA | 1.90029282 |
| 17 | PTK6 | 1.89085283 |
| 18 | CAMK1D | 1.85484371 |
| 19 | PAK4 | 1.72427437 |
| 20 | MAP3K10 | 1.70422956 |
| 21 | ICK | 1.65641734 |
| 22 | EPHB2 | 1.59702716 |
| 23 | DDR2 | 1.58543913 |
| 24 | EPHB1 | 1.55998690 |
| 25 | MST1R | 1.44319134 |
| 26 | FLT3 | 1.34699084 |
| 27 | STK38L | 1.33726519 |
| 28 | BMX | 1.30955381 |
| 29 | MTOR | 1.27975694 |
| 30 | STK3 | 1.27302564 |
| 31 | LATS2 | 1.21763159 |
| 32 | CDK6 | 1.15102429 |
| 33 | MET | 1.15002165 |
| 34 | PRPF4B | 1.14894478 |
| 35 | CAMK1G | 1.14849588 |
| 36 | KDR | 1.12753901 |
| 37 | PTK2 | 1.09628656 |
| 38 | TESK1 | 1.07628460 |
| 39 | INSRR | 1.07604357 |
| 40 | FER | 1.02401252 |
| 41 | MAP2K3 | 1.02186926 |
| 42 | NTRK1 | 1.01088644 |
| 43 | EPHA3 | 0.99527285 |
| 44 | PAK2 | 0.90908369 |
| 45 | TAOK3 | 0.89081838 |
| 46 | MAP3K3 | 0.89041695 |
| 47 | STK10 | 0.87255373 |
| 48 | LMTK2 | 0.87094712 |
| 49 | NEK9 | 0.86822532 |
| 50 | MAPK15 | 0.86028112 |
| 51 | NME2 | 0.84693360 |
| 52 | RPS6KB2 | 0.83699859 |
| 53 | IRAK3 | 0.82461944 |
| 54 | MAPK11 | 0.80230539 |
| 55 | FGFR2 | 0.79441491 |
| 56 | ERBB4 | 0.78254722 |
| 57 | PRKD3 | 0.77185059 |
| 58 | PDGFRB | 0.75951944 |
| 59 | PRKAA2 | 0.74374283 |
| 60 | TTK | 0.74050839 |
| 61 | CDK8 | 0.73244414 |
| 62 | CDK4 | 0.73022159 |
| 63 | ERBB2 | 0.71975065 |
| 64 | FRK | 0.71843911 |
| 65 | MARK2 | 0.71605730 |
| 66 | WNK4 | 0.71219981 |
| 67 | PDPK1 | 0.70458969 |
| 68 | LRRK2 | 0.70235332 |
| 69 | TGFBR1 | 0.69807513 |
| 70 | TRPM7 | 0.69693041 |
| 71 | DMPK | 0.69229758 |
| 72 | FGFR3 | 0.66684481 |
| 73 | RPS6KA2 | 0.66471834 |
| 74 | FGFR1 | 0.65159764 |
| 75 | MAP3K7 | 0.63200062 |
| 76 | TYK2 | 0.61623897 |
| 77 | CSF1R | 0.60834362 |
| 78 | CDK7 | 0.60139868 |
| 79 | MAPKAPK3 | 0.59917967 |
| 80 | GSK3A | 0.59738755 |
| 81 | SCYL2 | 0.57717301 |
| 82 | CHUK | 0.57642845 |
| 83 | CSK | 0.56595138 |
| 84 | STK4 | 0.56525584 |
| 85 | IRAK2 | 0.56315739 |
| 86 | MATK | 0.54130785 |
| 87 | TYRO3 | 0.53416768 |
| 88 | MAP2K2 | 0.51315300 |
| 89 | DYRK1B | 0.50178831 |
| 90 | JAK1 | 0.49933491 |
| 91 | MAP3K2 | 0.48219382 |
| 92 | BRD4 | 0.48206331 |
| 93 | PDK3 | 0.47465438 |
| 94 | PDK4 | 0.47465438 |
| 95 | PRKD1 | 0.47138541 |
| 96 | MAP3K8 | 0.45901060 |
| 97 | MAP3K1 | 0.43080376 |
| 98 | PIK3CG | 0.42890212 |
| 99 | STK38 | 0.42308213 |
| 100 | JAK2 | 0.41742042 |
| 101 | ILK | 0.41714073 |
| 102 | RPS6KA4 | 0.39686065 |
| 103 | AKT2 | 0.39495010 |
| 104 | NEK2 | 0.39400128 |
| 105 | MAP3K6 | 0.39392070 |
| 106 | RPS6KL1 | 0.38973937 |
| 107 | TAOK1 | 0.38478828 |
| 108 | PRKG2 | 0.37379667 |
| 109 | PRKAA1 | 0.36984837 |
| 110 | PRKD2 | 0.36730452 |
| 111 | CDK9 | 0.36602217 |
| 112 | HIPK2 | 0.36185717 |
| 113 | TAOK2 | 0.35622796 |
| 114 | CDC42BPA | 0.33740314 |
| 115 | PDK2 | 0.32948314 |
| 116 | ARAF | 0.31963672 |
| 117 | KSR2 | 0.31829763 |
| 118 | PRKCI | 0.31241219 |
| 119 | RET | 0.30523496 |
| 120 | MYLK | 0.29128592 |
| 121 | MELK | 0.28377442 |
| 122 | MAPK1 | 0.27909908 |
| 123 | MAPKAPK2 | 0.27907644 |
| 124 | CAMK4 | 0.27131765 |
| 125 | PIM2 | 0.27022352 |
| 126 | WNK1 | 0.26377557 |
| 127 | ABL2 | 0.26004465 |
| 128 | RPS6KA1 | 0.26000537 |
| 129 | RPS6KC1 | 0.25849954 |
| 130 | MAP2K1 | 0.22925992 |
| 131 | MAP3K11 | 0.22343908 |
| 132 | TESK2 | 0.21721053 |
| 133 | SRC | 0.21374473 |
| 134 | NME1 | 0.21315499 |
| 135 | RPS6KA6 | 0.20585734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.11165468 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76652647 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.70658933 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67189157 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60549674 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.52182374 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45663091 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35507844 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23320384 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20311896 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.07775965 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03315723 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94399779 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.94397366 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83037972 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82521400 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80991631 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80409833 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80362561 |
| 20 | Lysine degradation_Homo sapiens_hsa00310 | 1.71946272 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.63857352 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58512548 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55091347 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.55008662 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.53886207 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50863957 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49585226 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46737864 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.43969443 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39226041 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34966264 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.34944604 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.33536442 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33485923 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31173094 |
| 36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24152932 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.22924575 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21312099 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21284786 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17792563 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14670734 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.14313208 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12105280 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10879174 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.07094292 |
| 46 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03784174 |
| 47 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02978958 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02767016 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.02562227 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00126366 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99846404 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90565887 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90038933 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87272238 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85602248 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83496867 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83381171 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.82242048 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.80788075 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79534554 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78225648 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77761307 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77733650 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77708695 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.77326659 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77206003 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76628283 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75939512 |
| 69 | Tight junction_Homo sapiens_hsa04530 | 0.74077641 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73362846 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72369564 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72313046 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71522773 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71510114 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71173563 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.68539152 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68369061 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68200977 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65701980 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63622987 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62687005 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62592458 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61480378 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60026126 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59574761 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58430618 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57891960 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56323912 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55630475 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54647903 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54194528 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54147049 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53993648 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53259513 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53183123 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51086615 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50508913 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50504468 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.50151020 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49686521 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49584625 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49525710 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49219255 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47204934 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47176883 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44604506 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44121519 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.43713425 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43281808 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42206396 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41675435 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40676361 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39891079 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37170989 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36719338 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33638882 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33141899 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32259811 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.31753393 |
| 120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31696039 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31673305 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.28729952 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27338412 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27140415 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26344080 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26150558 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24291663 |

